Fundamental Analysis: Myomo
***Use our link or enter promo code “CCM” at checkout to get $10 off your first month at 7investing***
What is Myomo? Myomo is a medical device company that helps patients with partial arm paralysis regain the ability to use their limbs.
Valuation: EV/sales of 9.3, cash on hand to last another year at current burn rate, share count growing rapidly
Latest Earnings: 64% sales growth, $3.8M in revenue, 58% gross margins, $9M operating loss.
Our Future Growth Opportunities: Extend technology to different body parts. Updated designs that are less bulky.
Disclosure: The author and podcast guests are not financial advisors. Brett Schafer and Ryan Henderson are portfolio managers at Arch Capital. Clients of Arch Capital may hold securities discussed on this podcast.